A detailed history of Spire Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Spire Wealth Management holds 27,353 shares of ABBV stock, worth $4.54 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
27,353
Previous 30,239 9.54%
Holding current value
$4.54 Million
Previous $4.69 Million 6.27%
% of portfolio
0.17%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $461,240 - $525,540
-2,886 Reduced 9.54%
27,353 $4.98 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $3.96 Million - $4.47 Million
-28,814 Reduced 48.79%
30,239 $4.69 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $3.41 Million - $3.95 Million
25,536 Added 76.19%
59,053 $8.8 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $272,440 - $339,034
-2,056 Reduced 5.78%
33,517 $4.52 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $1.79 Million - $2.06 Million
12,360 Added 53.25%
35,573 $5.67 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $647,567 - $776,603
4,682 Added 25.27%
23,213 $3.75 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $4.6 Million - $5.28 Million
-34,292 Reduced 64.92%
18,531 $2.49 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $1.1 Million - $1.39 Million
-7,967 Reduced 13.11%
52,823 $8.09 Million
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $2.13 Million - $2.64 Million
-16,109 Reduced 20.95%
60,790 $9.86 Million
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $1.2 Million - $1.52 Million
11,214 Added 17.07%
76,899 $10.4 Million
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $323,243 - $366,929
-3,038 Reduced 4.42%
65,685 $7.09 Million
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $1.71 Million - $1.9 Million
-16,214 Reduced 19.09%
68,723 $7.73 Million
Q1 2021

May 21, 2021

BUY
$102.3 - $112.62 $8.69 Million - $9.57 Million
84,937 New
84,937 $8.81 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.